diet works glp-1 companion – StayWell dietworks glp-1 companion GLP-1 Companion

Meanwhile, adoption of existing medications for SUD is very low, particularly for AUD: AUD is a leading cause of mortality and morbidity, but compared with other chronic diseases such as cancers, hypertension, diabetes and depression, there is a very small number of US Food and Drug administration (FDA)-approved medications for AUD (acamprosate, disulfiram and naltrexone)

Semaglutide mimics the effects of GLP-1

Patients pay a flat monthly rate that includes the medical consult, the medication, and all required supplies

These medications are expensive due to high research costs, complex manufacturing processes, patent protection, and rising demand with limited supply